Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Free Men's Health Screening By Top Prostate Surgeon

Long-term, men with an elevated PSA or fluctuations in their PSA level are advised to seek the counsel of an expert in both prostate cancer and PSA monitoring. "One elevated result is not cause for alarm," Dr. Samadi explains, "It's important to partner with a specialist who has experience in interpreting PSA results year after year. Continuous monitoring and care offers men the greatest opportunity for early diagnosis and swift treatment."

Repeatedly high PSA levels can be followed by DREs, courses of antibiotics, and prostate biopsies, depending on the patient's unique circumstances. "I repeatedly witness the life-saving benefits of routine PSA screenings and, in my opinion, the treatment opportunities afforded by the PSA save a significant number of lives each year," said Dr. Samadi. A University of Rochester Medical Center study recently suggested that the PSA test and early detection may prevent as many as 17,000 metastatic prostate cancer cases each year http://onlinelibrary.wiley.com/doi/10.1002/cncr.27503/abstract.

Related Links:

http://www.roboticoncology.com http://www.smart-surgery.com

Related Videos:

PSA Test: Prostate Screening Saves Lives  - Click Here  http://www.youtube.com/watch?v=HYxPqdPdZIA&list=UUZvOHUgjV5EzAS-ZSOBeEGw&index=34

SMART Robotic Prostate Surgery - David Samadi, MD - Click Here http://www.youtube.com/watch?v=wRNPA5npn6Y&list=UUZvOHUgjV5EzAS-ZSOBeEGw&index=2

SEX AFTER PROSTATE CANCER : A Candid Look - Click Here http://www.youtube.com/watch?v=s7I0Q7mGhE0&list=UUZvOHUgjV5EzAS-ZSOBeEGw&index=4



 

 

 

SOURCE roboticoncology.com

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%
US 10 Yr 1.949% +0.084

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs